International Gemmological Institute (IGI) reported exceptional Q3 and 9M CY25 results, demonstrating robust growth across all business segments. Q3 revenues increased by 21%, with a 20% rise in EBITDA. The company processed nearly 3.5 million reports during the quarter. For the nine-month period, revenue grew by 15% and EBITDA by 22%, driven by strong performance in natural and lab-grown diamonds, jewelry, and colored stones.
Financial Performance Highlights
IGI has demonstrated significant growth momentum across all business segments in Q3 CY25 compared to Q3 CY24. Consolidated revenue from operations increased by 21%, and EBITDA grew by 20%. The company issued approximately 3.5 million reports in Q3 CY25, showcasing a volume growth of 26% over the previous year.
Segment Growth
The company experienced revenue growth across all segments, with lab-grown diamonds growing at 24% and natural diamonds growing at 29%. For the nine-month period ending in September 2025, revenue from operations grew by 15% and EBITDA by 22%. Volumes also increased by 25%, led by strong performance in natural diamonds, lab-grown diamonds, jewelry, and colored stones.
Key Financial Figures
Certification income for Q3 CY25 stood at INR 294 crores, representing a 20% increase year-over-year. Total revenues for the quarter were INR 304 crores, a 21% increase. The company delivered 3.45 million reports in the quarter, compared to 2.73 million in Q3 2024, a 26% increase.
Profit After Tax (PAT) was INR 130 crores, growing 18% year-over-year, with PAT margins at 43% for the quarter. EBITDA was reported at INR 176 crores, reflecting a 20% increase year-over-year, with EBITDA margin at 58%.
Nine-Month Performance
For the nine-month period, IGI delivered 9.6 million reports, compared to 7.7 million reports in the same period last year, a 25% increase. Certification income stood at INR 883 crores, a 16% increase, driven by growth across all key segments. PAT for the nine months stood at INR 397 crores, a 27% increase, with PAT margins at 44%.
EBITDA for the nine-month period was INR 545 crores, a 22% increase, with EBITDA margin at 60%. The company remains committed to delivering strong full-year performance in line with guidance, projecting over 15% revenue growth and 20% EBITDA growth.
Source: BSE
